APA (7th ed.) Citation

S, V., AR, K., S, J., SM, W., SR, S., M, M., . . . C, K. (2025). Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways. Cancer discovery, 15(3), 657. https://doi.org/10.1158/2159-8290.CD-25-0208

Chicago Style (17th ed.) Citation

S, Venneti, et al. "Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways." Cancer Discovery 15, no. 3 (2025): 657. https://doi.org/10.1158/2159-8290.CD-25-0208.

MLA (9th ed.) Citation

S, Venneti, et al. "Correction: Clinical Efficacy of ONC201 in H3K27M-Mutant Diffuse Midline Gliomas Is Driven by Disruption of Integrated Metabolic and Epigenetic Pathways." Cancer Discovery, vol. 15, no. 3, 2025, p. 657, https://doi.org/10.1158/2159-8290.CD-25-0208.